Olema Pharmaceuticals, Inc.

NasdaqGS:OLMA 株式レポート

時価総額:US$502.7m

Olema Pharmaceuticals 将来の成長

Future 基準チェック /06

Olema Pharmaceuticalsの収益は年間4.1%で減少すると予測されていますが、年間収益は年間77%で増加すると予測されています。EPS は年間 減少すると予測されています。自己資本利益率は 3 年後に-66.1% 4.1%なると予測されています。

主要情報

-4.1%

収益成長率

-4.1%

EPS成長率

Biotechs 収益成長28.3%
収益成長率77.0%
将来の株主資本利益率-66.1%
アナリストカバレッジ

Low

最終更新日20 Nov 2024

今後の成長に関する最新情報

Recent updates

Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth

Aug 29
Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth

Olema Pharmaceuticals: Still Merits A Small Holding

Jun 17

Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation

May 11
Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation

Palazestrant's Journey: Olema Pharmaceuticals' Long Oncology Path

Mar 28

Estimating The Fair Value Of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

Mar 04
Estimating The Fair Value Of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation

Nov 09
Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation

We're Keeping An Eye On Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate

Jun 11
We're Keeping An Eye On Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate

Will Olema Pharmaceuticals (NASDAQ:OLMA) Spend Its Cash Wisely?

Mar 01
Will Olema Pharmaceuticals (NASDAQ:OLMA) Spend Its Cash Wisely?

Olema Oncology grants stock options for 58.3K shares

Oct 05

We're Not Very Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate

Sep 13
We're Not Very Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate

Olema Pharmaceuticals GAAP EPS of -$0.82 misses by $0.18

Aug 09

Olema stock soars 12% as FDA grants fast track status to OP-1250 for breast cancer subtype

Jul 21

We Think Olema Pharmaceuticals (NASDAQ:OLMA) Can Easily Afford To Drive Business Growth

May 29
We Think Olema Pharmaceuticals (NASDAQ:OLMA) Can Easily Afford To Drive Business Growth

Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth

Feb 08
Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth

Our Take On Olema Pharmaceuticals

Jan 05

We're Not Very Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate

Sep 19
We're Not Very Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Rate

We Think Olema Pharmaceuticals (NASDAQ:OLMA) Can Afford To Drive Business Growth

Jun 04
We Think Olema Pharmaceuticals (NASDAQ:OLMA) Can Afford To Drive Business Growth

Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth

Feb 19
Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth

業績と収益の成長予測

NasdaqGS:OLMA - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20268-182-166N/A3
12/31/2025N/A-162-145-1375
12/31/2024N/A-133-108-785
9/30/2024N/A-123-97-97N/A
6/30/2024N/A-110-92-92N/A
3/31/2024N/A-99-87-87N/A
12/31/2023N/A-97-84-84N/A
9/30/2023N/A-96-85-85N/A
6/30/2023N/A-97-81-80N/A
3/31/2023N/A-110-85-85N/A
12/31/2022N/A-105-82-82N/A
9/30/2022N/A-100-82-81N/A
6/30/2022N/A-95-76-75N/A
3/31/2022N/A-79-59-58N/A
12/31/2021N/A-71-52-51N/A
9/30/2021N/A-60-42-41N/A
6/30/2021N/A-52-37-37N/A
3/31/2021N/A-38-29-29N/A
12/31/2020N/A-24-20-20N/A
9/30/2020N/A-15-12-12N/A
12/31/2019N/A-4-3-3N/A

アナリストによる今後の成長予測

収入対貯蓄率: OLMA今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: OLMA今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: OLMA今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: OLMA来年は収益がないと予測されています。

高い収益成長: OLMA来年は収益がないと予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: OLMA 3 年以内に赤字になると予測されています。


成長企業の発掘